To prove the involvement of SIRT1 in SIRT4-deficiency-induced malignancy, we established stable breast cancer cell lines (MDA-MB-468 and MCF-7) expressing two independent shRNAs that target SIRT1 and SIRT4. Here, SIRT1 is linked to breast cancer.